Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

UNBELIEVABLE: 2 - The Untold Story

Stock Market Today: Stocks End Mixed on the Day, Higher on the Week

The latest consumer sentiment data showed inflation concerns are on the rise.

Kiplinger

Novavax strikes $1.2 billion deal with Sanofi in major turnaround

It's a major turnaround for a drug company that warned last year about its ability to stay in business.

Axios

French, US Drug Firms Team Up For Covid-flu Shot

French pharmaceutical giant Sanofi and struggling US rival Novavax announced Friday an alliance to sell a Covid vaccine and develop another that combines with a flu shot.

International Business Times

From analysis to the latest developments in health,
read the most diverse news in one place.

Cheaper private Covid jabs may end up as costly as pricier ones, say experts

Exclusive: Multi-dose vials could push up charge per patient, with experts warning cost could widen inequalities

The Guardian - UK

Cost of private Covid jabs risks widening health inequalities, experts warn

Concerns that some groups who are more at risk from virus face hefty price tag, as Boots set to charge almost £100 a shot

The Guardian - UK

Pharmacies in England and Scotland to offer private Covid jabs – for £45

Pharmadoctor is offering appointments from 1 April for vaccinations and intends to add more pharmacies to its network

The Guardian - UK

Novavax COVID-19 vaccine approved

Vaccine uses different technology than Moderna and Pfizer's mRNA targeting strategy

Salon

Read news from The Economist, FT, and more,
with one subscription

US adds another option for fall COVID vaccination with updated Novavax shots

U.S. regulators have added another option for fall COVID-19 vaccination, updated shots made by Novavax

The Independent UK

Oxford-Serum institute malaria vaccine recommended for use by WHO

WHO recommends R21/Matrix-M malaria vaccine developed by Oxford and Serum Institute of India. Vaccine has met safety, quality and effectiveness standards. Serum Institute has established production capacity for 100 million doses/annum. Vaccine efficacy over 12 months is 75% at sites with high seasonal malaria transmission and 68% at sites with…

The Hindu

When and where can you get the updated COVID booster? And who needs one? What you need to know, according to experts

All Americans ages 6 months and older are eligible for the new jabs, the CDC said Tuesday.

Fortune

CDC greenlights two updated COVID-19 vaccines, but how will they fare against the latest variants? 5 questions answered

On Sept. 12, 2023, the Centers for Disease Control and Prevention recommended the newly formulated COVID-19 vaccines for all Americans ages 6 months and up, hours after its expert advisory committee voted 13 to 1 in favor of recommending the vaccines.

The Conversation

CDC OKs updated COVID-19 vaccine, clearing way for shots to begin this week

Chicago public health officials have said the CDC approval was all they needed to “begin the rollout” of the vaccine, which will be free for all city residents. “We already have the vaccine in Chicago,” Dr. Geraldine Luna, medical director for the Chicago Department of Public Health, said Monday.

Chicago Sun-Times

CDC panel recommends updated COVID vaccines. Shots could be ready this week

Americans may soon be able to get an updated COVID-19 vaccine

The Independent UK

FDA greenlights new COVID-19 shots for this fall - Roll Call

The FDA approved reformulated COVID-19 vaccines from Pfizer and Moderna, but deferred an expected authorization for Novavax’s vaccine.

Roll Call

Get all your
news in one place.

100's of premium titles.
One news app.

Inverse

When Should You Get Your Next Covid-19 Booster? There’s One Easy Answer To This Question

Vaccine manufacturers like Pfizer/BioNTech, Moderna, and Novavax are switching up their shots in preparation for the new season.

Tribune News Service

COVID boosters should be updated to target XBB strain, US health advisers say

COVID-19 shots should be reformulated to target an XBB subvariant of the highly infectious omicron strain to provide the best protection during the U.S. fall and winter season, health regulators said.

The Week

Sanofi: the new protein-based Covid vaccine to be used in the UK

The University of Edinburgh’s Neil Mabbott on the vaccine technology being used for Covid booster jabs from this month.

Wales Online

Everything we know about new Sanofi Covid vaccine now being used in UK

The vaccine being used in the Spring booster campaign works in a different way to previous jabs

Get all your
news in one place.

100's of premium titles.
One news app.

The Conversation

Sanofi vaccine: what to know about this protein-based COVID booster being offered in the UK

In the UK a spring booster campaign has recently begun, offering an additional vaccine to people at highest risk from COVID. Between April and June 2023 people aged over 75, residents in care homes and children and adults aged five and up with weakened immune systems will be invited to…

The Guardian - UK

Cancer and heart disease vaccines ‘ready by end of the decade’

Exclusive: Pharmaceutical firm says groundbreaking jabs could save millions of lives

Salon

Experts unsure about who needs boosters

FDA expert committee needs more data to decide when to give out COVID boosters — and who needs them most

Tribune News Service

FDA experts are still puzzled over who should get which COVID-19 shots and when

At a meeting to simplify the nation’s COVID-19 vaccination policy, the FDA’s panel of experts could agree on only one thing: Information is woefully lacking about how often different groups of Americans need to be vaccinated. That data gap has contributed to widespread skepticism, undervaccination, and ultimately unnecessary deaths from…

Reuters

FDA advisers back the same COVID vaccine for initial shots, boosters

Advisers to the U.S. Food and Drug Administration on Thursday unanimously voted in favor of targeting the same coronavirus strain for initial COVID-19 vaccine doses and boosters going forward, but some expressed skepticism about whether all Americans need to receive the shots annually.

Fortune

Vaccines are not making COVID strains like 'Kraken' stronger

Scientists say there is no evidence to suggest that vaccinations are making COVID "stronger" and that mutations are a normal part of virus evolution.

The Conversation

RSV: experts explain why rates of this virus are surging this year

Respiratory syncytial virus (RSV) is a very common virus, typically causing infection in children during the colder months. In most cases, RSV causes a mild illness, with symptoms similar to that of a regular cold.

1 2 3 4 5

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

the University of Edinburgh

245 stories

the Centers for Disease Control and Prevention

The National Institutes of Health

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.